These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease. Grünblatt E; Riederer P J Neural Transm (Vienna); 2016 Feb; 123(2):83-90. PubMed ID: 25298080 [TBL] [Abstract][Full Text] [Related]
48. Nato3 integrates with the Shh-Foxa2 transcriptional network regulating the differentiation of midbrain dopaminergic neurons. Nissim-Eliraz E; Zisman S; Schatz O; Ben-Arie N J Mol Neurosci; 2013 Sep; 51(1):13-27. PubMed ID: 23254923 [TBL] [Abstract][Full Text] [Related]
49. Dysregulation of core components of SCF complex in poly-glutamine disorders. Bhutani S; Das A; Maheshwari M; Lakhotia SC; Jana NR Cell Death Dis; 2012 Nov; 3(11):e428. PubMed ID: 23171848 [TBL] [Abstract][Full Text] [Related]
50. Genetic reduction of the E3 ubiquitin ligase element, SKP1A and environmental manipulation to emulate cardinal features of Parkinson's disease. Mandel SA; Fishman-Jacob T; Youdim MB Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S177-9. PubMed ID: 22166427 [TBL] [Abstract][Full Text] [Related]
51. A sporadic Parkinson's disease model via silencing of the ubiquitin-proteasome/E3 ligase component, SKP1A. Fishman-Jacob T; Youdim MBH J Neural Transm (Vienna); 2024 Jun; 131(6):675-707. PubMed ID: 37644186 [TBL] [Abstract][Full Text] [Related]